Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Sensei Biotherapeutics, Inc.

Latest From Sensei Biotherapeutics, Inc.

Finance Watch: Biopharma VC Deals On Track For A Record-Breaking Year

Private Company Edition: Venture capital invested in pharma and biotech in 2020 totaled $19.5m through Q3, just $400m below the full-year record total of $19.9bn in 2018. Also, Canaan and Catalio reveal new VC funds, while Talaris’s $115m series B leads recent financings.

Financing Innovation

Venture Funding Deals, January 2016

Derived from Strategic Transactions, Informa’s premium source for tracking life sciences deal activity, the Venture Funding Deals column provides a comprehensive monthly review of emerging life science companies that have received venture funding, including companies within the In Vitro Diagnostics, Medical Devices, and Pharmaceuticals sectors. This month’s column covers deals announced November through December 2015.

BioPharmaceutical Medical Device

Scrip Asia 100: Sales Blown Off Course By Currency Headwinds

Fiscal 2013 was a difficult year for Asian drug producers. 2013 drug revenues were $128 billion, 5.1% down on 2012 levels ($136 billion) across the 85 publicly-traded pharmaceutical companies that constitute the Scrip Asia 100.

BioPharmaceutical China

Powerful Parliamentary Committee Slams India’s Drug Regulator; Calls For Swift Overhaul

The committee unravels a system full of questionable practices and recommends complete overhaul of India’s drug regulator.

BioPharmaceutical India
See All

Company Information

  • Industry
  • Biotechnology
  • Pharmaceuticals
  • Pharmaceuticals
    • Vaccines
  • Other Names / Subsidiaries
    • Alvaxa Biosciences, Inc.
    • Panacea Global, Inc.
    • Panacea Pharmaceuticals, Inc.